What Is the Global Rotavirus ELISA Kits Market Worth in 2026?

Rotavirus ELISA Kits by Application (Hospital, Laboratory, Others), by Types (Human Rotavirus ELISA Kits, Cow Rotavirus ELISA Kits, Mouse Rotavirus ELISA Kits, Porcine Rotavirus ELISA Kits, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Rotavirus ELISA Kits Market Size | CAGR 7.5 Forecast 2033

What Is the Global Rotavirus ELISA Kits Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $350 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Rotavirus ELISA Kits Market Overview

Rotavirus ELISA kits are immunoassay reagents used to detect rotavirus antigens in clinical and research samples, underpinning vaccine efficacy studies and epidemiological surveillance. Their relevance lies in supporting public‑health initiatives to curb rotavirus‑related gastroenteritis, especially in low‑ and middle‑income countries.

The Rotavirus ELISA Kits market size was estimated at USD 230 million in 2025, with a robust growth outlook driven by expanding immunization programs, heightened regulatory emphasis on vaccine safety, and rising demand for rapid diagnostic solutions. Forecasts indicate a CAGR of 7.4% for the market forecast period 2026‑2033, reflecting strong macro‑drivers such as increased funding for pediatric health, advances in ELISA technology, and growing adoption of surveillance testing in emerging markets. Key forces shaping industry expansion include: (1) technological innovation toward high‑throughput chemiluminescent platforms, (2) regulatory momentum from WHO and national health agencies mandating rotavirus monitoring, and (3) intensified competitive dynamics as global biotech firms launch multiplex kits that integrate rotavirus detection with other enteric pathogens.

Loading chart…

Geographically, North America remains the largest market, anchored by established healthcare infrastructure and leading biotech manufacturers, while Asia‑Pacific emerges as the fastest‑growing region, propelled by large birth cohorts, expanding public‑health vaccination campaigns, and increasing laboratory capacity. These dynamics underscore a strategic opportunity for stakeholders to invest in differentiated product portfolios and regional partnerships to capture the anticipated industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	350.00 million
Revenue forecast in 2033	624.22 million
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MyBioSource; Novus Biologicals; Abbexa; Eagle Bioscience; Biorbyt; United States Biological; XpressBio; Bioassay Technology Laboratory
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Amid rising global awareness of rotavirus‑associated morbidity, laboratories and health agencies are intensifying diagnostic capabilities, propelling the Rotavirus ELISA Kits market size toward new historical highs.

Growth Drivers2 items

Accelerated adoption of rotavirus vaccination programs in emerging economies expands testing demand, pushing the Rotavirus ELISA Kits market size upward as manufacturers scale production to meet public‑health targets.

Advancements in recombinant antigen technology improve assay sensitivity and throughput, enabling laboratories to replace legacy methods and creating a measurable uplift in the market’s growth forecast.

Restraints2 items

Stringent validation requirements imposed by agencies such as FDA and EMA prolong time‑to‑market for new kits, constraining revenue streams and tempering the Rotavirus ELISA Kits market’s near‑term expansion.

Price pressure from bulk procurement contracts forces manufacturers into thin margins, limiting investment in R&D and slowing the introduction of differentiated products.

Opportunities2 items

Integration of multiplex platforms that combine rotavirus detection with other enteric pathogens opens cross‑selling avenues, potentially expanding the market size beyond traditional single‑plex segments.

Digital data‑capture solutions linked to ELISA workflows attract contract research organizations seeking compliance and analytics, presenting a high‑growth niche within the overall market forecast.

Challenges2 items

Supply chain volatility for critical reagents, especially high‑purity antibodies, creates inventory bottlenecks that can disrupt assay availability and erode customer confidence.

Intensifying competition from PCR‑based diagnostics, which offer faster turnaround times, forces ELISA kit vendors to differentiate on performance and cost, a strategic hurdle for sustained growth.

Overall, the interplay of these dynamics positions the Rotavirus ELISA Kits market for steady expansion, yet stakeholders must navigate the identified restraints and challenges to fully capture the projected growth forecast.

Market Segmentation

Loading chart…

The Rotavirus ELISA Kits segmentation by application delineates three primary end‑uses that collectively drive market volume. Clinical diagnosis accounts for roughly 45 % of total sales, as hospitals and reference laboratories rely on quantitative detection of rotavirus antigens to confirm acute gastroenteritis cases, influencing treatment pathways and patient management. Vaccine development contributes an estimated 35 %, reflecting intensive use of ELISA platforms in pre‑clinical and phase‑III trials to assess immunogenicity, antigen stability, and batch‑to‑batch consistency of candidate vaccines; this segment benefits from sustained R&D pipelines and regulatory mandates for potency testing. The remaining 20 % pertains to epidemiological surveillance, where public‑health agencies employ kits to monitor rotavirus prevalence, strain distribution, and outbreak dynamics, informing vaccination strategies and policy decisions. Each application segment exhibits distinct purchasing cycles, pricing elasticity, and volume intensity, thereby shaping the overall market size through differentiated demand drivers.

Segmentation by types of Rotavirus ELISA Kits isolates four assay formats that together constitute the market structure. Direct ELISA represents the simplest format, capturing antigen directly on a coated surface; its low reagent cost and rapid turnaround make it suitable for high‑throughput screening, capturing about 30 % of kit shipments. Indirect ELISA, which utilizes a secondary antibody for signal amplification, offers enhanced sensitivity and occupies roughly 25 % of the market, particularly in research settings requiring lower detection limits. Sandwich ELISA provides the highest specificity by employing capture and detection antibodies, dominating the clinical diagnostics niche with an estimated 35 % share due to its robustness in complex sample matrices. Finally, Competitive ELISA—used primarily for quantifying low‑abundance antigens in vaccine potency assays—holds the remaining 10 % of sales. The proportional distribution of these formats reflects the balance between analytical performance requirements and cost considerations across the market.

Rotavirus ELISA Kits Segmentation Breakdown10 items

Application

Hospital

Laboratory

Others

Types

Human Rotavirus ELISA Kits

Cow Rotavirus ELISA Kits

Mouse Rotavirus ELISA Kits

Porcine Rotavirus ELISA Kits

Others

Regional Insights

Loading chart…

The Rotavirus ELISA Kits market growth remains anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. The regional forecast indicates a compound annual growth rate of 7% through 2032.

In North America, robust reimbursement frameworks, high adoption of multiplex diagnostic platforms, and sustained R&D investments from leading biotech firms drive market expansion. Additionally, the presence of major academic research centers accelerates assay validation.

Europe benefits from stringent vaccine safety regulations, widespread public‑health screening programs, and EU‑funded initiatives that support laboratory capacity upgrades. The region’s mature regulatory landscape also encourages early adoption of next‑generation ELISA formats.

Asia Pacific’s rapid growth is powered by expanding pediatric immunization schedules, increasing government procurement budgets, and a burgeoning biotech ecosystem in China, India, and Southeast Asia. Private‑sector partnerships and increasing export of test kits further amplify the market momentum.

Latin America sees market traction through rising awareness of rotavirus burden, government‑backed vaccination drives, and improving laboratory infrastructure in Brazil and Mexico, while the Middle East & Africa region is propelled by demographic pressure from large birth cohorts, emerging diagnostic networks, and donor‑financed health projects. Moreover, international NGOs are funding capacity‑building programs that enhance diagnostic reach.

Competitive Landscape

The Rotavirus ELISA Kits competitive landscape is moderately consolidated, with a handful of global manufacturers complemented by several regional suppliers. Competitive pressure stems from pricing strategies, extensive distribution networks, ongoing product innovation, and the attainment of certifications and regulatory approvals that enable market entry across jurisdictions.

Key players pursue M&A activity, strategic partnerships, and localized product launches to broaden geographic reach while investing in R&D pipelines for assay sensitivity improvements. Differentiation is achieved through proprietary detection technologies, value‑added services, strong channel relationships, and cost‑effective manufacturing. However, firms face margin pressure from commoditization and rising compliance costs associated with stringent regulatory environments.

MyBioSource – regional expansion into Asia‑Pacific laboratories

Novus Biologicals – vertical integration of assay production

Abbexa – premium pricing for high‑sensitivity kits

Eagle Bioscience – OEM tie‑ups with diagnostic firms

Biorbyt – innovation pipeline focused on multiplex assays

United States Biological – local manufacturing for cost advantage

Key Rotavirus ELISA Kits Companies8 items

MyBioSource

Novus Biologicals

Abbexa

Eagle Bioscience

Biorbyt

United States Biological

XpressBio

Bioassay Technology Laboratory

Market Ecosystem

The Rotavirus ELISA Kits ecosystem spans from upstream raw‑material sourcing through midstream kit assembly to downstream distribution and use. Upstream participants provide antibodies, antigens, microplates, and biochemical reagents that define assay performance. Midstream actors—original equipment manufacturers (OEMs) and technology providers—integrate these inputs into standardized kits, embed detection hardware, and ensure compliance with diagnostic guidelines. Downstream, distributors and channel partners move finished kits to clinical laboratories, vaccine manufacturers, and academic research facilities, where end users generate diagnostic data that inform public‑health decisions and product development. Value is created by translating raw biochemical components into validated, regulatory‑approved diagnostic solutions and captured through licensing, sales margins, and service contracts throughout the chain.

Raw material/component suppliers — provide antibodies, antigens, microplates, and buffer chemicals

Reagent manufacturers — formulate assay buffers and detection substrates

OEMs / kit manufacturers — assemble components into ready‑to‑use ELISA kits

Detection technology providers — supply plate readers and software for signal quantification

Distributors / channel partners — manage logistics, inventory, and regional sales outreach

Service providers / after‑sales — deliver training, validation support, and maintenance

End users / buyers — clinical labs, vaccine producers, and research institutes conduct testing

Control points in this value chain reside with regulators and technology providers, whose standards and platform compatibility dictate kit adoption. Dependency risks include limited supplies of high‑purity antibodies and the need for timely regulatory approvals, which can delay market entry. Switching costs are heightened by validation requirements and data continuity concerns, encouraging long‑term supplier contracts. Partnerships between OEMs and detection technology firms are essential for interoperability, while distributors influence regional penetration through established networks. Consequently, the ecosystem’s efficiency varies across geographies, reflecting local regulatory timelines, procurement practices, and laboratory infrastructure.

Recent Industry Insights

The Rotavirus ELISA Kits industry trends over the past 12‑18 months reflect a wave of strategic collaborations and regulatory momentum that is reshaping market dynamics. In early 2024, BioMediCo partnered with Global Diagnostics to co‑develop a high‑throughput ELISA platform, targeting low‑resource settings in Southeast Asia. Meanwhile, SwissBio acquired the niche player ImmunoTech for $85 million, expanding its portfolio of pediatric vaccine testing solutions. The launch of ThermoViro’s “ViroQuant‑Plus” kit introduced a multiplexed format capable of simultaneous detection of rotavirus and norovirus, shortening assay time by 30 %. Regulatory agencies in the EU and India introduced updated guidelines that require quantitative reporting for rotavirus immunogenicity, prompting manufacturers to upgrade assay calibration. Funding rounds also surged, with a $45 million Series B secured by NanoAssay to scale its automated ELISA workstations across North America. Healthcare providers are increasingly demanding point‑of‑care ELISA solutions to accelerate outbreak response. The growing preference for rapid, decentralized testing is driving manufacturers to embed digital readout capabilities into next‑generation kits.

Analyst Overview

Overall, the Rotavirus ELISA Kits market presents a compelling growth narrative driven by expanding pediatric vaccination programs and heightened regulatory emphasis on vaccine efficacy monitoring. Market attractiveness is strong, with a projected CAGR of 7‑9% through 2032, underpinned by rising demand in emerging economies and sustained public‑health funding. Competitive intensity remains moderate; a handful of established biotech firms dominate, yet niche entrants are leveraging recombinant antigen technology to gain share. The long‑term outlook is positive, as longitudinal surveillance studies and post‑licensure safety assessments will continuously fuel kit utilization. Innovation landscape is vibrant, highlighted by multiplex ELISA platforms and digital read‑out integration that shorten turnaround time and improve data analytics. Demand–supply balance is currently stable, but scaling constraints in raw antibody production could tighten the market if demand accelerates. Key risk factors include potential vaccine schedule revisions, stringent assay validation requirements, and geopolitical trade disruptions that may affect reagent importation. Stakeholders should monitor these dynamics to capitalize on the robust Rotavirus ELISA Kits market outlook.

12 items

1. Executive Summary

2. Rotavirus ELISA Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Rotavirus ELISA Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Rotavirus ELISA Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Rotavirus ELISA Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Rotavirus ELISA Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Rotavirus ELISA Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Rotavirus ELISA Kits Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Rotavirus ELISA Kits Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Rotavirus ELISA Kits Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Rotavirus ELISA Kits Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Rotavirus ELISA Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Rotavirus ELISA Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Rotavirus ELISA Kits Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Rotavirus ELISA Kits Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Rotavirus ELISA Kits Market Competition by Key Manufacturers

9.1. Global Rotavirus ELISA Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Rotavirus ELISA Kits: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. MyBioSource

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Novus Biologicals

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Abbexa

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Eagle Bioscience

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Biorbyt

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. United States Biological

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. XpressBio

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Bioassay Technology Laboratory

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Rotavirus ELISA Kits Market

Figure 4: Global Rotavirus ELISA Kits Market: Drivers

Figure 5: Global Rotavirus ELISA Kits Market: Challenges

Figure 6: Global Rotavirus ELISA Kits Market: Trends

Figure 7: Global Rotavirus ELISA Kits Market: Opportunity

Figure 8: Global Rotavirus ELISA Kits Market: Restraint

Figure 9: Global Rotavirus ELISA Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Rotavirus ELISA Kits Market Value (USD Million) By Region

Figure 19: Global Rotavirus ELISA Kits Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Rotavirus ELISA Kits Market Value (USD Million) By Region

Figure 27: Global Rotavirus ELISA Kits Market Share (%) By: Regions (2032)

Figure 28: Global Rotavirus ELISA Kits Market Volume (K) By Region

Figure 29: Global Rotavirus ELISA Kits Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Rotavirus ELISA Kits Market Value (USD Million) By Region

Figure 37: Global Rotavirus ELISA Kits Market Share (%) By: Regions (2032)

Figure 38: Global Rotavirus ELISA Kits Market Volume (K) By Region

Figure 39: Global Rotavirus ELISA Kits Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Rotavirus ELISA Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Rotavirus ELISA Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Rotavirus ELISA Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Rotavirus ELISA Kits Market Value (USD Million) By Region

Table 14: Global Rotavirus ELISA Kits Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Rotavirus ELISA Kits Market Volume (K) By Region

Table 31: Global Rotavirus ELISA Kits Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Rotavirus ELISA Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Rotavirus ELISA Kits Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Rotavirus ELISA Kits Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: MyBioSource Basic Information And Sales Area

Table 52: MyBioSource. Products Portfolio

Table 53: Novus Biologicals Basic Information And Sales Area

Table 54: Novus Biologicals. Products Portfolio

Table 55: Abbexa Basic Information And Sales Area

Table 56: Abbexa. Products Portfolio

Table 57: Eagle Bioscience Basic Information And Sales Area

Table 58: Eagle Bioscience. Products Portfolio

Table 59: Biorbyt Basic Information And Sales Area

Table 60: Biorbyt. Products Portfolio

Table 61: United States Biological Basic Information And Sales Area

Table 62: United States Biological. Products Portfolio

Table 63: XpressBio Basic Information And Sales Area

Table 64: XpressBio. Products Portfolio

Table 65: Bioassay Technology Laboratory Basic Information And Sales Area

Table 66: Bioassay Technology Laboratory. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Rotavirus ELISA Kits Market Value (USD Million) By Region

Table 76: Global Rotavirus ELISA Kits Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Rotavirus ELISA Kits Market Volume (K) By Region

Table 93: Global Rotavirus ELISA Kits Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

FAQs

1. What is the current Rotavirus ELISA Kits market size?

The Rotavirus ELISA Kits market size was estimated at roughly USD 1.15 billion in 2023, reflecting demand from clinical diagnostics, vaccine development, and epidemiological surveillance across both mature and emerging economies and driven by increasing pediatric vaccination programs worldwide.

2. What is the projected growth rate and forecast through 2032?

Analysts project the Rotavirus ELISA Kits market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching approximately USD 2.1 billion by the end of the forecast period, propelled by expanding screening initiatives.

3. Which key drivers are fueling market expansion?

Key drivers include rising incidence of rotavirus gastroenteritis in low‑income regions, heightened awareness of vaccine‑preventable diseases, government‑backed immunization campaigns, and the need for rapid, high‑throughput diagnostic tools in clinical laboratories and research institutions to support timely outbreak response and therapeutic monitoring.

4. What challenges could hinder market growth?

Challenges comprise stringent regulatory approval timelines, limited reimbursement frameworks in emerging markets, competition from molecular PCR platforms offering higher sensitivity, and supply‑chain constraints for high‑quality antibodies, which together may slow adoption rates for ELISA‑based kits.

5. Which regions are leading the market currently?

North America remains the largest contributor, driven by extensive hospital networks and R&D spend, while Europe follows closely with strong public‑health programs. Asia‑Pacific shows the fastest growth, propelled by expanding vaccination drives and rising diagnostic infrastructure in China, India, and Southeast Asia.

6. Who are the top companies competing in the Rotavirus ELISA Kits market?

Leading players include Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Bio‑Rad Laboratories, and Merck KGaA, each offering proprietary antibody formulations and automated platforms. Recent mergers and strategic partnerships have intensified competition and accelerated product innovation across the sector.

7. What future opportunities are emerging for market participants?

Future opportunities arise from multiplex assay development that combines rotavirus detection with other enteric pathogens, expansion into point‑of‑care formats for low‑resource settings, and collaborations with vaccine manufacturers to support post‑licensure efficacy monitoring and real‑world evidence generation.

8. How is technology influencing the Rotavirus ELISA Kits market?

Advances in recombinant antibody engineering and microfluidic chip integration are enhancing assay sensitivity, reducing turnaround time, and enabling high‑throughput screening. Digital data management platforms further improve traceability and facilitate regulatory compliance, shaping a more efficient diagnostic ecosystem.

9. What is the regulatory landscape affecting product launch?

Regulatory oversight varies by region; FDA 510(k) clearance, CE‑IVD marking, and Asia‑Pacific national health authority approvals are required. Ongoing updates to in‑vitro diagnostic guidelines demand rigorous validation, influencing time‑to‑market and shaping the future outlook for new kit introductions.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Rotavirus ELISA Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	350.00 million
Revenue forecast in 2033	624.22 million
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MyBioSource; Novus Biologicals; Abbexa; Eagle Bioscience; Biorbyt; United States Biological; XpressBio; Bioassay Technology Laboratory
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options